INTRODUCTION {#sec1-1}
============

Stress response under anesthesia has been universally recognized phenomenon which may be in the form of endocrine or autonomic disturbance. The pressure response to laryngoscopy and endotracheal intubation in form of tachycardia, hypertension and arrhythmias may be potentially dangerous. These changes are the maximum at 1 minute after intubation and last for 5-10 min.\[[@CIT1]\]

There is substantial evidence that, laryngoscopy and intubation is accompanied by a considerable increase in heart rate and arterial blood pressure. These changes are usually of short duration and well-tolerated by patients in the absence of cardiovascular disease or disturbed intracranial pressure homeostasis. In these conditions, an increase in blood pressure may lead to complications, including arrhythmias, myocardial ischemia, increase in intracranial pressure and rupture of cerebral aneurysms.\[[@CIT2][@CIT3]\]

Various methods of attenuation of response to laryngoscopy and intubation are still in search from the date of its recognition. Several studies have been made in order to attenuate these haemodynamic response to laryngoscopy and intubation. Many drugs also have been used for the same purpose.\[[@CIT4]--[@CIT10]\]

Esmolol is an ultra-short acting β-1 adrenergic blocker. It has predominant effect on β-receptors and possesses no significant membrane stabilizing activity. It has rapid onset and a short duration of action.\[[@CIT11]--[@CIT12]\]

Fentanyl is a phenylpiperidine of the 4-amino piper dine series, structurally related to, but not derived from pethidine.\[[@CIT13]\]

The aim of this study is to do a comparative study of esmolol and fentanyl in attenuating the pressure response during laryngoscopy and intubation.

METHODS {#sec1-2}
=======

After taking permission from hospital ethics committee and with the patients' consent, we studied 90 patients of either sex weighing 35-60 kg, aged between 15-55 years were included in the study. All the patients were belonging to ASA grade I and II and were scheduled for elective surgical procedures.

Patients with predicted difficult intubation, hypertension, ischemic heart disease, compensatory tachycardia, baseline pulse \<60 bpm, baseline systolic B.P. \<100 mm Hg, chronic obstructive airway disease, on medicines with cardiovascular effects were and excluded from the study.

All patients were premedicated with 0.2 mg i.v. injection glycopyrrolate 10 min before surgery. Pulse, bloodpressure, SPO~2~, ECG were recorded before as well as after premedication. Pulse, systolic and diastolic blood pressure, oxygen saturation, were monitored continuously and recorded before premedication, after premedication and after intubation at 1, 3, 5, 15, 30, 45, 60, 75, 90 minutes and postoperatively. In group E and group F all these parameters were also recorded after drug i.e., esmolol and fentanyl, respectively.

Patients were divided into three groups:

  ---------- ---------------------------------------------------------------------------------------------
  Group C:   Normal saline was given. (Control)
  Group E:   Injection esmolol 2 mg/kg i.v. 3 min before laryngoscopy and intubation, over 30 seconds.
  Group F:   Injection fentanyl 2 µg/kg i.v. 3 min before lar yngoscopy and intubation, over 30 seconds.
  ---------- ---------------------------------------------------------------------------------------------

After preoxygenation and 3 min after the administration of the study drug, induction was done with injection thiopentone sodium 5 mg/kg and injection suxamethonium 1.5 mg/kg. Laryngoscopy and endotracheal intubation was performed 90 second after the administration of succinylcholine. In all the groups intubation was done with Macintosh curve blade with in a period of 15 seconds. Failure to intubate in this period and difficult intubation cases were excluded from this study. After confirming the position of the ET tube and fixing it anesthesia was maintained with 33% O~2~ and 66% N~2~O. Injection vecuronium was used as a muscle relaxant. Pulse, systolic and diastolic blood pressure, O~2~ saturation and ECG were monitored continuously and recorded at timely interval. At the end of the surgery all patients were reversed by using injection Neostigmine 0.05 mg/kg and injection glycopyrollate 8 µg/kg intravenously. Patients were then shifted to anesthesia recovery room and monitored for complications like pain, nausea, vomiting, respiratory depression, hypertension, hypotension, bradycardia, drowsiness and rigidity.

For statistical analysis of data within the groups, paired Students '*t*' test was used while for comparison between groups unpaired '*t*' test was used. Results were considered statistically significant for *P* values *P*\< 0.05.

RESULTS {#sec1-3}
=======

Cases were selected from different specificity (general surgery, gynecology, orthopedics, ENT). The demographical data was compared among the three groups. No statistically significant difference between the groups was observed with respect to age, gender or weight.

[Table 1](#T0001){ref-type="table"} shows demographical data of all three groups. In group C mean age of patients was 31.3±2.38, group F was 32.83±10.5 and group E was 32.66±3.99. In group C there were 16 females and 14 males with a ratio of 1:1.14, group F there were 14 females and 16 males with a ratio of 1:0.87, group E there were 17 females and 13 males with a ratio of 1:1.30. Weight distribution (in kgs) in group E was 53.73±2.64, in group F was 54.70±4.35 and group C was 54.06±2.64.

###### 

Demographical profile of the study group

  Patient characteristics   Ratio of mean (SD)            
  ------------------------- -------------------- -------- --------
  Sex (M:F)                 1:1.31               1:1.08   1:1.43
  Age (years)               31.13                32.83    32.66
  Bodyweight (kg)           54.06                54.70    53.73

[Table 2](#T0002){ref-type="table"} shows change in mean pulse rate and mean arterial pressure and [Table 3](#T0003){ref-type="table"} shows in rate pressure product, in all three groups compared with their respective preinduction value at different stages \[Figures [1](#F0001){ref-type="fig"}--[3](#F0003){ref-type="fig"}\].

![Graph showing comprehensive changes in rate pressure product](SJA-5-2-g001){#F0001}

![Graph showing changes in mean pulse rate](SJA-5-2-g002){#F0002}

![Graph showing comprehensive changes in mean arterial pressure](SJA-5-2-g003){#F0003}

###### 

Changes in the mean pulse rate and mean arterial blood pressure in all three groups

  Time                                  Mean pulse rate   Mean arterial blood pressure                               
  ----------------------------- ------- ----------------- ------------------------------ -------- --------- -------- --------
  Before premedication          Mean    82.2              85.2                           83.6     93.36     93.73    93.29
                                Range   72-92             68-109                         64-110   83-100    85-102   83-105
                                S.D.    ±5.47             ±7.60                          ±10.37   ±5.41     ±4.52    ±5.66
  After drug                    Mean    86.8              75.53                          82.93    94.10     91.45    98.69
                                Range   74-96             60-84                          64-98    84-104    82-97    83-97
                                S.D.    ±5.05             ±6.76                          ±8.95    ± 3.93    ±3.74    ±4.68
  After induction               Mean    81.53             79.73                          83.53    87.85     88.24    101.06
                                Range   72-92             80-104                         62-94    77-95     82-90    92-105
                                S.D.    ±5.01             ±7.73                          ±4.32    ±4.47     ±3.92    ±3.03
  After intubation              Mean    107.33            91.66                          95.86    110.56    96.70    103.88
                                Range   98-116            86-104                         88-104   100-112   92-103   93-110
                                S.D.    ±4.82             ±5.01                          ±4.69    ±3.24     ±3.32    ±3.60
  1 minute after intubation     Mean    101.8             88.33                          92.86    107.47    92.76    99.85
                                Range   96-108            76-100                         86-100   96-107    93-100   87-101
                                S.D.    ±4.34             ±5.28                          ±3.95    ±3.09     ±3.11    ±3.61
  3 minutes after intubation    Mean    97                85.33                          88.2     100.68    90.76    96.32
                                Range   90-106            76-94                          82-94    94-106    93-97    87-101
                                S.D.    ±4.44             ±4.61                          ±3.45    ±3.02     ±1.83    ±3.55
  5 minutes after intubation    Mean    93.33             83.00                          84.66    97.46     90.49    93.69
                                Range   82-100            74-88                          80-90    93-102    89-96    83-101
                                S.D.    ±4.82             ±3.88                          ±3.25    ±2.67     ±1.97    ±3.43
  15 minutes after intubation   Mean    87.93             79.93                          82.13    96.66     90.11    90.16
                                Range   80-100            68-88                          76-90    86-99     82-94    82-97
                                S.D.    ±4.59             ±4.31                          ±3.10    ±3.20     ±3.65    ±3.85

###### 

Changes in the rate pressure product in all three groups

  Time                                  Group C       Group E      Group F
  ----------------------------- ------- ------------- ------------ -------------
  Before premedication          Mean    9946.26       10431.4      10241.1
                                Range   7920-1440     7920-11440   6784-14960
                                S.D.    ±897.60       ±1286.2      ±1703.33
  After drug                    Mean    10558.4       8672.4       9986.13
                                Range   8288-11760    6572-10400   7040-12740
                                S.D.    ± 815.81      ±1017.2      ±1388.21
  After induction               Mean    9269.2        8150.06      10039.67
                                Range   8000-10836    6572-9826    10080-14144
                                S.D.    ±635.22       ±863.95      ±914.31
  After intubation              Mean    15772.27      12396.7      13724
                                Range   12740-19560   9980-14144   9382-14560
                                S.D.    ±1233.88      ±941.03      ±2223.34
  1 minute after intubation     Mean    14269.93      11414.93     12348.8
                                Range   12480-16200   9600-1300    10800-14016
                                S.D.    ±939.63       ±861.43      ±734.11
  3 minutes after intubation    Mean    13134.8       10590.13     11651.6
                                Range   11700-15180   9120-11960   9900-12521
                                S.D.    ±903.32       ±746.75      ±1680.80
  5 minutes after intubation    Mean    12258         10129.93     10419.73
                                Range   10080-13720   9120-11440   8692-11696
                                S.D.    ±910.28       ±645.141     ±663.83
  15 minutes after intubation   Mean    11043.07      9403.06      9663.6
                                Range   9600-12600    7208-10584   8360-11440
                                S.D.    ±4.59         ±754.48      ±668.52

The increase in heart rate at intubation was seen in all the three groups the baseline value. But the rise was minimal in group F and group E as compared to group C, which was statistically significant (*P*\<0.05). Also, only in the group E, there was no significant rise at any time interval (*P*\<0.001). These changes were significant up to 15 min postintubation \[[Table 4](#T0004){ref-type="table"}\].

###### 

Changes in heart rate at various time interval (mean ± SD)

  Groups               After drug                                  After induction                            After intubation                              1 min after intubation                        3 min after intubation                        5 min after intubation                        15 min after intubation
  -------------------- ------------------------------------------- ------------------------------------------ --------------------------------------------- --------------------------------------------- --------------------------------------------- --------------------------------------------- -------------------------------------------
  Group E              75.53±6.76                                  79.73±7.73                                 91.66±5.01                                    88.33±5.28                                    85.33±4.61                                    83.00±3.88                                    79.33±4.31
  *P* value (ctrl/E)   0.042[\*](#T000F1){ref-type="table-fn"}     \<0.05[\*](#T000F1){ref-type="table-fn"}   \<0.001[\*\*](#T000F2){ref-type="table-fn"}   \<0.001[\*\*](#T000F2){ref-type="table-fn"}   \<0.001[\*\*](#T000F2){ref-type="table-fn"}   \<0.001[\*\*](#T000F2){ref-type="table-fn"}   0.001[\*\*](#T000F2){ref-type="table-fn"}
  Group F              82.93±8.95                                  83.53±4.32                                 95.86±4.69                                    92.86±3.95                                    88.2±3.45                                     84.66±3.25                                    82.13±3.10
  *P* value (ctrl/F)   \<0.041[\*](#T000F1){ref-type="table-fn"}   0.270                                      \<0.001[\*\*](#T000F2){ref-type="table-fn"}   \<0.001[\*\*](#T000F2){ref-type="table-fn"}   \<0.001[\*\*](#T000F2){ref-type="table-fn"}   \<0.01[\*](#T000F1){ref-type="table-fn"}      \<0.01[\*](#T000F1){ref-type="table-fn"}

= Significant,

= Highly significant

Compared with baseline value, systolic blood pressure, diastolic blood pressure and mean blood pressure were increased in all the three groups after laryngoscopy and intubation and at different time intervals. The increase in mean arterial pressure was least in group E and maximal in group C. The rise was highly significant immediately after intubation in group C (*P*\<0.001) and significant from (*P*\<0.05) in group F while was not significant in group E (*P*\>0.005) \[[Table 5](#T0005){ref-type="table"}\].

###### 

Changes in mean arterial pressure at various time interval (mean ± SD)

  Groups               After drug   After induction                               After intubation                               1 min after intubation                         3 min after intubation                         5 min after intubation                        15 min after intubation
  -------------------- ------------ --------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- --------------------------------------------- -------------------------------------------
  Group E              93.73±4.52   88.24±3.92                                    96.70±3.32                                     92.76±3.11                                     90.76±1.83                                     90.49±3.65                                    90.11±3.64
  *P* value (ctrl/E)                \<0.001[\*\*](#T000F4){ref-type="table-fn"}   \<0.0001[\*\*](#T000F4){ref-type="table-fn"}   \<0.0001[\*\*](#T000F4){ref-type="table-fn"}   \<0.0001[\*\*](#T000F4){ref-type="table-fn"}   \<0.001[\*\*](#T000F4){ref-type="table-fn"}   0.001[\*\*](#T000F4){ref-type="table-fn"}
  Group F              93.29±5.66   101.06±3.03                                   103.88±3.60                                    99.85±3.61                                     96.32±3.55                                     93.69±3.43                                    90.16±3.85
  *P* value                         0.0001[\*\*](#T000F4){ref-type="table-fn"}    \<0.0001[\*\*](#T000F4){ref-type="table-fn"}   \<0.0005[\*\*](#T000F4){ref-type="table-fn"}   \<0.0001[\*\*](#T000F4){ref-type="table-fn"}   \<0.001[\*\*](#T000F4){ref-type="table-fn"}   \<0.05[\*](#T000F3){ref-type="table-fn"}

= Significant,

Highly significant

The changes in MAP were significant up to 15 min postintubation after which the systolic blood pressure, diastolic blood pressure and mean arterial pressure declined gradually and reached to baseline levels after 15 min of laryngoscopy and intubation in all the three groups. The RPP was calculated as the product of heart rate and systolic arterial pressure. In our study the RPP during intubation revealed a highly significant (*P*\<0.001) increase in group C and group F, whereas the increase was insignificant in group E. These changes were highly significant up to 15 min postintubation (*P*\<0.001).

While comparing group F to group E these was highly significant (*P*\<0.001) increase in RPP in group F at the time of intubation and was statistically significant (*P*\<0.01) at all the instances.

[Table 3](#T0003){ref-type="table"} is showing the comprehensive changes in the mean rate pressure product in all three groups. RPP is calculated as: RPP=SAP×SR. The mean RPP in group C, raise from 10136.67 ±1893.8to15772.27 ± 635.22 with a rise of 5636, which was highly significant than in group E, where the difference in the value of mean RPP after premedication and after intubation was 1508 while the same was 2103 in group F. These changes remain significant even after 15 min of intubation. The rise in mean RPP was least in group E and highest in group C. the changes were seen significant in group E compared to group C, even after 30 min of intubation.

DISCUSSION {#sec1-4}
==========

The pressure response to laryngoscopy and endotracheal intubation in form of tachycardia and hypertension occurs frequently; even α-adrenoreceptor blockade minimizes increases in heart rate and myocardial contractility (primary determinants of O~2~ consumption) by attenuation effects of increased adrenergic activity. This is particularly derivative in patients with IHD.\[[@CIT12]--[@CIT13]\]

More attention is given to the use of selective β-adrenergic antagonists to prevent the reflex sympathoadrenal discharge-mediated tachycardia and hypertension during procedures of laryngoscopy and endotracheal intubation and these include esmolol.\[[@CIT14]\]

Esmolol has been used in various bolus does or in an infusion form. Esmolol, 2 mg/kg, as a single bolus successfully attenuated the pressure response. There was minimal increase in heart rate than the other group but the blood pressure showed a rise although it was less than other groups after laryngoscopy and endotracheal intubation.\[[@CIT15]\]

Again our study correlates with the study of Liu Philip *et al*. who used esmolol infusion to control hemodynamic responses associated with intubation. They found significant decreases in RPP prior to induction and postintubation the increase was 50% less in the esmolol-treated patients compared to the placebo group.\[[@CIT16]\]

Christopher *et al*. used esmolol 1-2 mg/kg and concluded that the increase in heart rate and blood pressure associated with laryngoscopy and endotracheal intubation were significantly lower in comparison to the control group.\[[@CIT17]\]

Sabahat *et al*. used esmolol 1 mg/kg and concluded that esmolol partially attenuated the hemodynamic response but did not abolish it completely. Esmolol in bolus doses 100 mg and 200 mg attenuates tachycardia and hypertension after tracheal intubation.\[[@CIT18]\]

Esmolol group did not reveal any rhythm abnormality. No ST segment changes were seen in any patients.

Narcotics may block afferent nerve impulses resulting from stimulation of the pharynx and larynx during intubation

Fentanyl has also been used in different doses varying from 2 to 15 µg/kg to blunt haemodynamic responses to laryngoscopy and endotracheal intubation. Low doses of fentanyl, 2 µg / kg were used in our study and the efficacy was compared with esmolol group.

It was found that with fentanyl, 2 µg/kg elevation of heart rate and blood pressure after intubation was lower than control group, although not statistically significant.

Yushi *et al*. in his study concluded that 2 µg/kg fentanyl suppresses the hemodynamic response to endotracheal intubation more than the response to laryngoscopy.\[[@CIT19]\]

It was shown that supplementation of anesthetic induction with fentanyl 2 µg/kg significantly attenuated the increase in heart rate, arterial pressure and rate pressure product after laryngoscopy and intubation, and fentanyl 6 µg/kg completely abolished pressure responses.\[[@CIT20]\]

Doses of fentanyl that are low enough to same little postoperative respiratory depression significantly blunt postintubation hypertension when used as adjoins to thiopental. This was demonstrated in a study conducted by Donald E. Martin *et al*. who used fentanyl, 8 µg/kg in patients undergoing major vascular surgery.\[[@CIT20]--[@CIT21]\]

Low doses of fentanyl were employed because a large dose was lead to muscular rigidity, bradycardia, nausea and vomiting. Large doses may also cause postoperative respiratory depression; especially in surgery with short duration of less than 1 hour.\[[@CIT22]\] McClain *et al*. reported apnoeic episodes in four out of seven patients who received 3.2-6.5 µg/kg fentanyl.\[[@CIT23]\]

CONCLUSION {#sec1-5}
==========

From the present study it is evident that both esmolol in a bolus dose of 2mg/kg and fentanyl in bolus dose of 2 µg/kg before induction of anesthesia are effective in attenuating the hemodynamic responses to laryngoscopy and endotracheal intubation like heart rate and rate pressure product.

But only esmolol provided consistent and reliable protection against increases in both heart rate and systolic blood pressure accompanying laryngoscopy and endotracheal intubation.

No evidence of any myocardial insult was seen in any of the patients in any group in our study.

It is advisable and safe to use esmolol in patients who are prone to have exaggerated responses of cardiovascular system during laryngoscopy and intubation.
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